The incidence of HCV antibodies has been evaluated in 123 chronic hemodialysis (HD) patients (Group A; 55 M and 68 F) and in 37 consecutive HD patients (group B) admitted to our hospitals for acute hepatitis. In group A, HCV antibodies were present in 27% of the patients. 20 of 36 (55%) had previously received blood transfusions. 21 patients (58%) were also positive for HBV Ab. In 8 patients, ALT were significantly increased. In group B, the diagnosis of HCV-related acute hepatitis was made in 11 patients. 8 of them had previously received blood transfusions. Seroconversion occurred 2-3 months after onset of the disease.
As changes of erythrocyte glutathione metabolism i s a sensitive index of the i n v i v o o x i d a t i v e processes, reduced glutathione /CSH/ , oxidized glutathione/ CSSC/ s t a b i l i t y od CSH and oxidation 3tate o f haemoglobin have been measured. Data$ hd 11 c h i l d r e w i t h acute c e l i a s disease/ ACS/ 11 chlldt.en on gluten f r e e d i e t / CFCD / were compared t o those of 11 c h i l d r e n w i t h n u t r i t i v e i r o n deticiency/ NlDl and t o 11 healthy c h i l d r e n .IS controls. Erythrocyte CSH content of ACD qroup elevated s i g n i f i c a n t l y , the CSSC level decreased compared t o nornlal controls CSSC and CSSCICSH r a t i o n also d i f f e r e d from those o f NID group, and a marked d i f f e r e n c e haa been measured i n glutathione s t a b i l i t y , too. I n ACD group methaenloglobin and haenlicrom were measured. Anomalies of erythrocyte metabolism normaliaed durina the d i e t oeriod. The decreased CSSC/ CSH value of ACD arouD A . r e f e r s t o decreaged a r t i v i t i o f seleoocnzym gluathione peroxidase, a s > g n i f i c a n t selenium deficiency /228*158nq/gHb/ has been proved t o normal controls 14655 136ng/qHb/.Our r e s u l t s suggesL t h a t during gluten challenge ACO p a t i e n t s suffer from chronic oxidant stress which p a r t i a l l y can be explained by the weakness of scavanger system and by seleniunl deficiency.
AREA UNDER p H 4 : ADVANTAGES OF
12Y v a n V a n d e n p l a s , A n i t a ~o o s s e n s , M i a M a r i c h a l . A c a d e m i c C h i l d r e n ' s H o s p i t a l F r e e U n i v e r s i t y o f B r u s s e l s . 2 4 H o u r e s o p h a q e a l p H n o n i t o r i n q h a s become t h e p r e f e r r e d t e s t t o . . . q u a n t i f y a c i d g a s t r o -e s o p h a g e a l r e f l u x . A g r e e m e n t h a s b e e n a c h i e v e d t h a t r e f l u x e d a c i d g a s t r i c c o n t e n t i n t o t h e e s o p h a g u s c o n s t i t u t c s a m a j o r c a u s e o f r e f l u x e s o p h a g i t i s . K e t h e r c f o r e c a l c u l a t e d t h e a s a r e a u n e e r p H 4 " (A) i n 5 6 0 c o n s e c u t i v e p f l m o n i t i n i n f a n t s 1-12 m o n t h s o l d , a n d r e l a t e d t h i s p a r a m e t e r t o t h e % t i m e w i t h pf1<4 ( r e f l u x i n -
T h e "P." i s r e l a t k d t o t h e R I w h e r e a s a c c o r d i n g t o t h e I 1 1 t h e "A" i n c r e a s e s s i g n i f i c a n t l y ( p < 0 . 0 0 1 ) ; t h e h i g h SD, h o w e v e r , o b t a i n e d i n e a c h g r o u p i l l u s t r a t e s t h e G r e a t v a r i a b i l i t y i n ' A " ( o r a c i d i t y o f t h e r e f l u x e p i s o d e s ) i n a l l g r o u p s . E s o g h a g o s c o p y ( a n d b i o p s y ) w a s p e r f o r m e d i n 1 1 2 i n f a n t s ( 2 0 % ) . S p e c i f i c i t y i n t h e p r e d i c t i o n o f e s o p h a g i t i s w a s h i g h e r f o r t h e "A" ( 8 8 % ) c o m p a r e d t ot h e 31 ( 5 0 8 1 . S e n s i t i v i t y o f b o t h p a r a n l e t e r s w a s c o m p a r a b l e ( 9 6 % v e r s u...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.